Europe approves childhood epilepsy treatment
UCB’s FINTEPLA (fenfluramine) oral solution has been approved in the European Union (EU) for the…
UCB’s FINTEPLA (fenfluramine) oral solution has been approved in the European Union (EU) for the…
Metrion Biosciences Limited, and The KCNC1 Foundation are to collaborate to try and find a…
Neuraxpharm Group, a European pharmaceutical company focused on the treatment of central nervous system (CNS)…
UCB has announced the publication of long-term open-label extension (OLE) study results of FINTEPLA (fenfluramine)…
Scientists at Aston University in the U.K. have started work on a project that will…
A wearable medical device that can give an early warning of an epileptic seizure has…
SK Biopharmaceuticals, Co., Ltd. says Health Canada has accepted Paladin Labs Inc.'s filing of a…
Global biopharma company UCB says the UK’s National Institute for Healthcare Excellence (NICE) has issued…
Accure Therapeutics, a neurology biotech targeting central nervous system (CNS) conditions such as multiple sclerosis…
One of the biggest Series A rounds in European biotech, €159M ($180M), has been raised…
GW Pharmaceuticals, a British biotech developing cannabinoid drugs, is on a high after a successful…
Update (26/06/2018): The FDA has approved GW Pharmaceutical's drug Epidiolex in two severe forms of epilepsy.…